HUCMSCs reduced IL-1β and IL-1α levels, inhibited MDA and ROS production levels, and increased SOD, CAT, and GSH-px levels in the in vitro model of premature ovarian failure, as shown in Figures 2(a)–(2j). Here, IL1A is linked to primary ovarian failure.